Neuphoria Therapeutics Inc.
NEUP · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $14 | $14,211 | $17 | $4 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $12 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $0 | $818 | $0 | $0 |
| Total Curr. Assets | $14 | $15,041 | $17 | $4 |
| Property Plant & Equip (Net) | $0 | $105 | $0 | $0 |
| Goodwill | $9 | $8,639 | $8 | $8 |
| Intangibles | $5 | $4,805 | $5 | $5 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | -$0 | $0 |
| Total NC Assets | $13 | $13,549 | $14 | $14 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $27 | $28,590 | $31 | $18 |
| Liabilities | – | – | – | – |
| Payables | $1 | $1,154 | $1 | $2 |
| Short-Term Debt | $0 | $116 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $4 | $2,950 | $1 | $0 |
| Total Curr. Liab. | $5 | $4,221 | $2 | $2 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $495 | $1 | $1 |
| Other NC Liab. | $9 | $4,871 | $2 | $1 |
| Total NC Liab. | $10 | $5,366 | $3 | $2 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $15 | $9,587 | $5 | $4 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$188 | -$178,347 | -$169 | -$181 |
| AOCI | -$3 | -$2,845 | -$4 | -$4 |
| Other Equity | $204 | $200,194 | $199 | $198 |
| Total Equity | $13 | $19,003 | $26 | $14 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $27 | $28,590 | $31 | $18 |
| Net Debt | -$14 | -$14,094 | -$17 | -$4 |